Description
Rituximab, marketed under the brand name REDITUX, It is an prescription medication that has been approved rituximab (brand name Rituxan) on November 26, 1997. It was the first monoclonal antibody approved to treat lymphoma.
What is REDITUX (Rituximab) ?
Reditux is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is a monoclonal antibody. Monoclonal antibodies are a relatively new type of “targeted” cancer therapy.
Rituximab is used to treat non-Hodgkin’s lymphoma or chronic lymphocytic leukemia. This medicine is also used in combination with another drug to treat symptoms of adult rheumatoid arthritis. It is also used in combination with steroid medicines to treat certain rare disorders that cause inflammation of blood vessels and other tissues in the body.
How to order approved “REDITUX (Rituximab) for Injection” Medicine?
REDITUX (Rituximab) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing REDITUX and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.





